Notice of Results

Notice of Results

ID: 20244

(Thomson Reuters ONE) -


Summit Corporation plc
("Summit" or "the Company")


NOTICE OF PRELIMINARY RESULTS

Oxford, UK, 4 May 2010, Summit (AIM: SUMM), a UK drug discovery Company with
partner funded programmes and an innovative SeglinTM (second generation
iminosugar) technology platform for the discovery of new medicines, will be
announcing its preliminary results for the year ended 31 January 2010 on
Thursday, 6 May 2010.

- END -

For more information, please contact:

Summit

Steven Lee, PhD

Richard Pye, PhD Tel: +44 (0)1235 443939



Singer Capital Markets (Nominated
Adviser)

Shaun Dobson / Claes Spång Tel: +44 (0)20 3205 7500



Peckwater PR

Tarquin  Edwards Tel: +44 (0)7879 458 364
tarquin.edwards(at)peckwaterpr.co.uk
uk>


About Summit

Summit is an Oxford, UK based drug discovery company with a portfolio of partner
funded drug programmes and an innovative technology platform called SeglinsTM
for the discovery of new medicines.

Summit's partnered drug programmes require no further investment from the
Company but have contractual, success-based milestones potentially worth in
excess of $160 million and sales royalties rising to a low teen percentage.
 Partners include leading orphan drug specialist BioMarin Pharmaceuticals
(Duchenne Muscular Dystrophy programme) and the Wellcome Trust (C. difficile
programme).

SeglinTM technology
SeglinTM technology is using new chemistry to access biological drug targets
that cannot be exploited by conventional drug discovery approaches.  Summit's




internal research is currently focussed in the high value therapy areas of type
II diabetes and infectious diseases and the Company will further exploit the
technology's wider potential through strategic alliances.

Summit is listed on the AIM market of the London Stock Exchange and trades under
the ticker symbol SUMM.  Further information is available at www.summitplc.com
.



[HUG#1411748]









Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  TRANSPARANCY OBLIGATIONS UNDER THE DUTCH ACT - EU TRANSPARENCY DIRECTIVE RVA Holding AB - Portfolio Company Greenvironment lists on Frankfurt Stock Exchange
Bereitgestellt von Benutzer: hugin
Datum: 04.05.2010 - 16:51 Uhr
Sprache: Deutsch
News-ID 20244
Anzahl Zeichen: 0

contact information:
Town:

Abingdon,



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 150 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Notice of Results"
steht unter der journalistisch-redaktionellen Verantwortung von

Summit Corporation PLC (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Publication of Circular and Notice of General Meeting ...

Summit Corporation plc ("Summit" or "the Company") POSTING OF CIRCULAR AND NOTICE OF GENERAL MEETING Oxford, UK, 14 December 2009 - Summit Corporation plc (AIM: SUMM) is pleased to announce that further to the announcement made ...

Alle Meldungen von Summit Corporation PLC



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z